Adverse Event Reporting
An “Adverse Event” is any new, undesirable medical experience or change in an existing condition which occurs during or after use of any marketed or investigational product. Amgen staff are required to report Adverse Events within one business day.
Antitrust and Unfair Competition
Amgen does not tolerate any business transaction or activity that violates the antitrust and competition laws of any country in which the company conducts business.
Compliance Reporting and Non-Retaliation Policy
Amgen provides an effective process for Amgen staff or their representatives to express concerns and report potential violations regarding Amgen business conduct without retaliation or intimidation.
Conflicts of Interest
Amgen staff are responsible for avoiding situations in which personal interests, outside activities, financial interests or relationships conflict or even appear to conflict with the company’s interests.
Dealing with the Government
Amgen has a strict policy against any attempt to unlawfully influence government officials.
Environmental Health and Safety
Amgen is committed to excellence in environmental, health and safety performance.
Export Control Laws
Amgen complies with all U.S. export control laws which may restrict the export of goods, software, and technology from the United States.
Foriegn Corrupt Practices
Amgen maintains a strict policy against paying, offering to pay, or authorizing the payment of anything of value to any foreign (i.e. non-U.S.) government official, government staff member, political party or political candidate in an attempt to influence a person working in an official capacity.
Insider Trading
Amgen’s policy against insider trading applies to staff members, consultants, contract workers and temporary staff, as well as to members of their families and households.
Interactions with Healthcare Professionals
Amgen requires that all interactions with healthcare professionals and other customers comply with all applicable laws and adhere to the highest standards of professional ethics and responsibility.
Pricing
Accurate and timely pricing information about Amgen’s products can assist healthcare providers, government and private payers, patients, and other stakeholders. The calculation, reporting and disclosure of pricing information are also important to Amgen’s commercial success as well as a part of our legal and regulatory obligations.
Professional Conduct
Ethical business conduct, professional behavior, adherence to acceptable business principles, personal integrity and compliance with applicable laws and regulations are expected to be consistently demonstrated at Amgen.
Promotional Materials and Activities
All of Amgen's U.S. promotional materials are reviewed for rigorous consistency with FDA-approved product labeling. Our marketing practices are based on valid scientific evidence.
Protection of Personal Information Policy
Amgen is committed to the lawful stewardship of personal information that is collected, stored and used by the company.
R&D and Manufacturing in a Regulated Environment
It is Amgen’s policy to comply with all applicable laws and regulations regarding its research, development and manufacturing activities, including Good Operating Practices.
Scientific Exchange
Amgen is committed to truthful, non-misleading exchange of medical and scientific information, including clear and objective communications of risks, benefits, and safety.
